Statistics

Total Visits

Views
Maintenance bacillus Calmette-Guerin immunotherapy for TaG3 or T1G3 and/or carcinoma in situ transitional cell carcinoma of the bladder: Final results of the randomized CUETO Group Study 9801364

Select a period of time:

Number of views in the range

Views
Maintenance bacillus Calmette-Guerin immunotherapy for TaG3 or T1G3 and/or carcinoma in situ transitional cell carcinoma of the bladder: Final results of the randomized CUETO Group Study 9801325

Views

Views
October 20250
November 20258
December 20255
January 20263
February 20260
March 20269
April 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States9
Brazil4
Poland4
Bulgaria4
Argentina1
Ecuador1
Nicaragua1
Turkey1
 

Top cities views

Views
Ashburn5
Brooklyn1
Caxias do Sul1
Cotia1
Monte Grande1
Quito1
Ribeirão das Neves1
Teresópolis1
İskenderun1